September 21-23, 2020 | 10:00AM EDT | 2:00PM UTC*
*Program is in development and subject to change
Proteomics provides critical biological information about the activation state of enzymes, pathways, and signaling networks that drive all biological processes. However, the power of this approach is currently limited by the capabilities of proteomics technologies and methods. Although single dimensional proteomics analysis is now routine on abundant samples, challenges remain in analyzing limited samples collected from in vivo studies and in examining dynamic cellular processes. This meeting aims to address these challenges, focusing on the latest advances and innovations in sample preparation, instrumentation, and bioinformatic/computational analysis, to push the boundaries of proteomics to enable more powerful analytics for translational research.
Specifically, the program will cover:
A critical focus of this virtual meeting will be on new technologies needed to further improve the feasibility of looking at multicellular dimensions & multiplexed analyses in proteomics. The program features diverse content on current biological applications and needs, highlighting the application of high sensitivity proteomics to real-world translational questions. Participants will learn what instrumentation, data acquisition methods, and informatic pipelines allow researchers to answer critical yet challenging questions, while also learning what is not yet feasible. By bringing together a multidisciplinary team of experts across a broad range of fields through digital technologies, this virtual meeting aims to stimulate a collaborative environment and cross-pollination of ideas to drive the next wave of innovation in proteomics approaches and technologies. We will also discuss how we can better work together as a community to disseminate these methods and analytical tools, similar to recent movements in the open source computational programming world. Ultimately our goal is to help build a proteomics community that is ready to tackle even the most complex biological problems.
Program is intended for scientific researchers and clinical audiences.
Join us for this landmark virtual event, brought to you by Keystone Symposia.
Registration for this meeting is now closed.
Abstract Submission: Passed
Speaking at this eSymposia
Brigham and Womens Hospital, USA
Matthew S. Bogyo
Stanford University School of Medicine, USA
Institute of Cancer Research, UK
Claudia Andrea Escher
Biognosys AG, Switzerland
Lunenfeld-Tanenbaum Research Institute, Canada
SomaLogic, Inc, USA
David E. James
University of Sydney, Australia
Brigham Young University, USA
Jennie R. Lill
Genentech, Inc., USA
Kathryn S. Lilley
University of Cambridge, UK
Uppsala University, Sweden
Edward M. Marcotte
University of Texas at Austin, USA
Ghent University, Belgium
Genentech, Inc., USA
European Molecular Biology Laboratory, Germany
Alice Y. Ting
Stanford University, USA
Newcastle University, UK
Northeastern University, USA
Jonathan S. Weissman
University of California, San Francisco, USA
Forest M. White
Massachusetts Institute of Technology, USA
ETH Zürich, Switzerland
Gavin J. Wright
Wellcome Trust Sanger Institute, UK
Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.